- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07754071
Clinical Validation of an Artificial Intelligence System for De-termining Fetal Lie and Position in 3rd Trimester
Clinical Validation of an Artificial Intelligence System for Determining Fetal Lie and Position in 3rd Trimester
Study Overview
Status
Detailed Description
Accurate assessment of fetal lie and presentation during the third trimester is essential for obstetric management and delivery planning. Ultrasound is the gold standard for determining fetal orientation; however, the examination is highly operator-dependent and requires considerable experience to correctly identify fetal anatomy and orientation. Artificial intelligence (AI)-based navigational support systems have the potential to assist clinicians by providing real-time guidance during ultrasound examinations and improving the consistency of fetal orientation assessment.
The purpose of this study is to prospectively validate an AI-based navigational support system for determining fetal lie and presentation during routine third-trimester ultrasound examinations. The system analyzes blind ultrasound sweeps acquired along the maternal midline and automatically predicts fetal lie and presentation. AI-generated predictions will be compared with expert clinician assessment, which serves as the reference standard.
Eligible pregnant women attending third-trimester ultrasound examinations at the Fetal Medicine Department, Rigshospitalet, Slagelse - or Hillerød hospital, will be invited to participate. Following written informed consent, an expert clinician will first determine fetal lie and presentation as part of the routine ultrasound examination. The same clinician will subsequently acquire three blind ultrasound sweeps along the maternal midline. The AI navigational support system will analyze each sweep and generate predictions of fetal lie and presentation. All examinations will be completed within 5-10 minutes to minimize changes in fetal orientation between the clinical assessment and AI evaluation.
The primary objective is to evaluate the diagnostic performance of the AI system by comparing AI-generated predictions with expert clinician assessment. Primary outcome measures include overall diagnostic accuracy and agreement,
These findings will provide additional insight into the feasibility of implementing AI-assisted navigational support in routine obstetric ultrasound practice.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mary Le Ngo, MD, MD
- Phone Number: +45 20773779
- Email: mary.van.anh.le.ngo.01@regionh.dk
Study Locations
-
-
-
Slagelse, Denmark, 3450
- Not yet recruiting
- Slagelse Hospital, Department of Obstetrics and Gynecology
-
Contact:
- Kathinka Nyborg, MD
- Phone Number: 20773779
- Email: kany@regionsjaelland.dk
-
-
Capital Region
-
Hillerød, Capital Region, Denmark, 3400
- Not yet recruiting
- Nordsjællands Hospital, Department of Obstetrics and Gynecology
-
Contact:
- Gitte Hedermann, Associate Professor
- Phone Number: +2520773779
- Email: gitte.hedermann.christensen@regionh.dk
-
-
København Ø
-
Copenhagen, København Ø, Denmark, 2100
- Recruiting
- Rigshospitalet - Department of Obstetrics and Gynecology
-
Contact:
- Martin Tolsgaard, professor,, Medical doctor, Ph.D
- Phone Number: +4520773779
- Email: martin.groennebaek.tolsgaard@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant women aged ≥18 years.
- Singleton pregnancy.
- Gestational age ≥28+0 weeks.
- Fetus in longitudinal lie (cephalic or breech presentation) as determined by the routine clinical ultrasound examination.
- Able to understand Danish or English.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- Multiple pregnancy.
- Fetus in transverse lie.
- Inability to provide written informed consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Prospective Clinical Validation Cohort
Pregnant women with singleton pregnancies in the third trimester (≥28+0 weeks' gestation) undergoing obstetric ultrasound examination.
Participants undergo three blind ultrasound sweeps, and AI-generated predictions of fetal lie and presentation are compared with expert clinician assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of the AI navigational support system for determining fetal lie and presentation.
Time Frame: During the study ultrasound examination (approximately 5 minutes).
|
Overall proportion of correct AI predictions of fetal lie and presentation compared with expert clinician assessment (reference standard).
|
During the study ultrasound examination (approximately 5 minutes).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agreement between AI predictions and expert clinician assessment.
Time Frame: During the study ultrasound examination.
|
Agreement will be evaluated using Cohen's kappa coefficient.
|
During the study ultrasound examination.
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-2019-3101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.